Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ATAI LIFE SCIENCES N.V.

(ATAI)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Berenberg Bank Adjusts Atai Life Sciences' Price Target to $38 From $35, Maintains Buy Rating

11/17/2021 | 07:52am EST


ę MT Newswires 2021
All news about ATAI LIFE SCIENCES N.V.
01/12ATAI LIFE SCIENCES : FDA Grants Investigational New Drug to PCN-101 R-ketamine Program
DJ
01/12Atai Life Sciences Receives FDA Clearance to Conduct Anti-Depressant Study
MT
01/12Atai Life Sciences announces FDA Investigational New Drug (IND) Clearance for PCN-101 R..
AQ
01/12Atai Life Sciences Announces Fda Investigational New Drug Clearance for Pcn-101 R-Ketam..
CI
01/06RBC Cuts Price Target on Atai Life Sciences to $12 From $17, Maintains Sector Perform R..
MT
2021European ADRs Move Lower in Monday Trading
MT
2021ATAI LIFE SCIENCES N.V.(NASDAQGM : ATAI) added to S&P Global BMI Index
CI
2021ATAI LIFE SCIENCES N.V.(NASDAQGM : ATAI) added to NASDAQ Biotechnology Index
CI
2021European ADRs Move Higher in Thursday Trading
MT
2021Atai Impact Establishes the atai Fellowship Fund in Psychedelic Neuroscience with Massa..
AQ
More news
Analyst Recommendations on ATAI LIFE SCIENCES N.V.
More recommendations
Financials (USD)
Sales 2021 17,2 M - -
Net income 2021 -116 M - -
Net cash 2021 385 M - -
P/E ratio 2021 -6,17x
Yield 2021 -
Capitalization 811 M 811 M -
EV / Sales 2021 24,7x
EV / Sales 2022 8 648x
Nbr of Employees 35
Free-Float 90,8%
Chart ATAI LIFE SCIENCES N.V.
Duration : Period :
Atai Life Sciences N.V. Technical Analysis Chart | ATAI | NL0015000DX5 | MarketScreener
Technical analysis trends ATAI LIFE SCIENCES N.V.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 14
Last Close Price 5,06 $
Average target price 28,54 $
Spread / Average Target 464%
EPS Revisions
Managers and Directors
Florian Brand Chief Executive Officer
Gregory L. Weaver Chief Financial Officer
Srinivas G. Rao Chief Scientific Officer
Rolando GutÝerrez-Esteinou Chief Medical Officer
Alexis Marc Joel Louis de Rosnay Independent Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
ATAI LIFE SCIENCES N.V.-33.68%811
MODERNA, INC.-39.94%61 847
LONZA GROUP AG-20.30%49 060
IQVIA HOLDINGS INC.-16.27%45 129
SEAGEN INC.-19.08%22 875
ICON PUBLIC LIMITED COMPANY-19.15%20 381